1 |
Alrushaid, S., Davies, N. M., Martinez, S. E. and Sayre, C. L. 2016. Pharmacological characterization of Liquiritigenin, a chiral flavonoid in licorice. Res. Pharm. Sci. 11, 355-365.
DOI
|
2 |
Ariyasu, D., Yoshida, H. and Hasegawa, Y. 2017. Endoplasmic Reticulum (ER) stress and endocrine disorders. Int. J. Mol. Sci. 18.
|
3 |
Belmokhtar, C. A., Hillion, J. and Segal-Bendirdjian, E. 2001. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene 20, 3354-3362.
DOI
|
4 |
Passante, E., Wurstle, M. L., Hellwig, C. T., Leverkus, M. and Rehm, M. 2013. Systems analysis of apoptosis protein expression allows the case-specific prediction of cell death responsiveness of melanoma cells. Cell Death Differ. 20, 1521-1531.
DOI
|
5 |
Shimizu, S., Narita, M. and Tsujimoto, Y. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
DOI
|
6 |
Simon, H. U., Haj-Yehia, A. and Levi-Schaffer, F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418.
DOI
|
7 |
Singh, S. K., Banerjee, S., Acosta, E. P., Lillard, J. W. and Singh, R. 2017. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget 8, 17216-17228.
DOI
|
8 |
Wang, D., Lu, J., Liu, Y., Meng, Q., Xie, J., Wang, Z. and Teng, L. 2014. Liquiritigenin induces tumor cell death through mitogen-activated protein kinase- (MPAKs-) mediated pathway in hepatocellular carcinoma cells. Biomed. Res. Int. 2014, 965316.
|
9 |
Taylor, W. R. and Stark, G. R. 2001. Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
DOI
|
10 |
Vilen, S. T., Salo, T., Sorsa, T. and Nyberg, P. 2013. Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal 2013, 920595.
|
11 |
Wang, D., Wong, H. K., Feng, Y. B. and Zhang, Z. J. 2014. Liquiritigenin exhibits antitumour action in pituitary adenoma cells via Ras/ERKs and ROS-dependent mitochondrial signalling pathways. J. Pharm. Pharmacol. 66, 408-417.
DOI
|
12 |
Wong, R. S. 2011. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87.
DOI
|
13 |
Dickinson, B. C. and Chang, C. J. 2011. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 7, 504-511.
DOI
|
14 |
Bundela, S., Sharma, A. and Bisen, P. S. 2014. Potential therapeutic targets for oral cancer: ADM, TP53, EGFR, LYN, CTLA4, SKIL, CTGF, CD70. PLoS One 9, e102610.
DOI
|
15 |
Chen, J. 2016. The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb. Perspect. Med. 6, a026104.
DOI
|
16 |
Degli Esposti, M. and Dive, C. 2003. Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res. Commun. 304, 455-461.
DOI
|
17 |
Elmore, S. 2007. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516.
DOI
|
18 |
Fulda, S. and Debatin, K. M. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811.
DOI
|
19 |
Ge, G., Yan, Y. and Cai, H. 2017. Ginsenoside Rh2 inhibited proliferation by inducing ROS Mediated ER stress dependent apoptosis in lung cancer cells. Biol. Pharm. Bull. 40, 2117-2124.
DOI
|
20 |
Green, D. R. and Kroemer, G. 2004. The pathophysiology of mitochondrial cell death. Science 305, 626-629.
DOI
|
21 |
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y. and Sakuragi, N. 2014. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 150845.
|
22 |
Hata, A. N., Engelman, J. A. and Faber, A. C. 2015. The BCL2 Family: Key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 5, 475-487.
DOI
|
23 |
Zheng, Y. Z., Cao, Z. G., Hu, X. and Shao, Z. M. 2014. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. Breast Cancer Res. Treat. 145, 349-358.
DOI
|
24 |
Zhou, Y., Wang, K., Zhen, S., Wang, R. and Luo, W. 2016. Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21 (Waf1/Cip1) and p27(Kip1). Taiwan J. Obstet. Gynecol. 55, 847-851.
DOI
|
25 |
Lee, S. H., Meng, X. W., Flatten, K. S., Loegering, D. A. and Kaufmann, S. H. 2013. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death Differ. 20, 64-76.
DOI
|
26 |
Yuan, X., Li, T., Xiao, E., Zhao, H., Li, Y., Fu, S., Gan, L., Wang, Z., Zheng, Q. and Wang, Z. 2014. Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis. Food Chem. Toxicol. 65, 242-251.
DOI
|
27 |
Huang, C. H. and Chan, W. H. 2017. Protective effects of Liquiritigenin against citrinin-triggered, oxidative-stressmediated apoptosis and disruption of embryonic development in mouse blastocysts. Int. J. Mol. Sci. 18, pii:E2538.
|
28 |
Kardeh, S., Ashkani-Esfahani, S. and Alizadeh, A. M. 2014. Paradoxical action of reactive oxygen species in creation and therapy of cancer. Eur. J. Pharmacol. 735, 150-168.
DOI
|
29 |
Kishimoto, K., Yoshida, S., Ibaragi, S., Yoshioka, N., Hu, G. F. and Sasaki, A. 2014. Neamine inhibits oral cancer progression by suppressing angiogenin-mediated angiogenesis and cancer cell proliferation. Anticancer Res. 34, 2113-2121.
|
30 |
Kumar, M., Nanavati, R., Modi, T. G. and Dobariya, C. 2016. Oral cancer: Etiology and risk factors: A review. J. Cancer Res. Ther. 12, 458-463.
DOI
|
31 |
Leibowitz, B. and Yu, J. 2010. Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol. Ther. 9, 417-422.
DOI
|
32 |
Liu, C., Wang, Y., Xie, S., Zhou, Y., Ren, X., Li, X. and Cai, Y. 2011. Liquiritigenin induces mitochondria-mediated apoptosis via cytochrome c release and caspases activation in HeLa Cells. Phytother. Res. 25, 277-283.
DOI
|
33 |
Mishra, D., Singh, S. and Narayan, G. 2016. Curcumin induces apoptosis in Pre-B acute lymphoblastic Leukemia cell lines via PARP-1 cleavage. Asian Pac. J. Cancer Prev. 17, 3865-3869.
DOI
|
34 |
Liu, Y., Xie, S., Wang, Y., Luo, K., Wang, Y. and Cai, Y. 2012. Liquiritigenin inhibits tumor growth and vascularization in a mouse model of HeLa cells. Molecules 17, 7206-7216.
DOI
|
35 |
Lu, W., Feng, F., Xu, J., Lu, X., Wang, S., Wang, L., Lu, H., Wei, M., Yang, G., Wang, L., Lu, Z., Liu, Y. and Lei, X. 2014. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2. Cancer Biol. Ther. 15, 1174-1184.
DOI
|
36 |
Ma, Y., Zhang, J., Zhang, Q., Chen, P., Song, J., Yu, S., Liu, H., Liu, F., Song, C., Yang, D. and Liu, J. 2014. Adenosine induces apoptosis in human liver cancer cells through ROS production and mitochondrial dysfunction. Biochem. Biophys. Res. Commun. 448, 8-14.
DOI
|
37 |
Mersereau, J. E., Levy, N., Staub, R. E., Baggett, S., Zogovic, T., Chow, S., Ricke, W. A., Tagliaferri, M., Cohen, I., Bjeldanes, L. F. and Leitman, D. C. 2008. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol. Cell Endocrinol. 283, 49-57.
DOI
|
38 |
Mills, C. C., Kolb, E. A. and Sampson, V. B. 2017. Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer. Cancer Res. 77, 6489-6498.
DOI
|
39 |
Mukherjee, A. K., Basu, S., Sarkar, N. and Ghosh, A. C. 2001. Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 8, 1467-1486.
DOI
|
40 |
Oh, H., Yoon, G., Shin, J. C., Park, S. M., Cho, S. S., Cho, J. H., Lee, M. H., Liu, K., Cho, Y. S., Chae, J. I. and Shim, J. H. 2016. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways. Int. J. Oncol. 48, 1749-1757.
DOI
|
41 |
Oh, H. N., Seo, J. H., Lee, M. H., Kim, C., Kim, E., Yoon, G., Cho, S. S., Cho, Y. S., Choi, H. W., Shim, J. H. and Chae, J. I. 2018. Licochalcone C induced apoptosis in human oral squamous cell carcinoma cells by regulation of the JAK2/STAT3 signaling pathway. J. Cell Biochem. 119, 10118-10130.
DOI
|
42 |
Oh, H. N., Seo, J. H., Lee, M. H., Yoon, G., Cho, S. S., Liu, K., Choi, H., Oh, K. B., Cho, Y. S., Kim, H., Han, A. L., Chae, J. I. and Shim, J. H. 2018. Oridonin induces apoptosis in oral squamous cell carcinoma probably through the generation of reactive oxygen species and the p38/JNK MAPK pathway. Int. J. Oncol. 52, 1749-1759.
|